Glucocorticoid receptor-activator protein-I interactions in drug design.
Wade
E J
EJ
Forschungszentrum Karlsruhe, Institute of Genetics, Germany.
Heck
S
S
Cato
A C
AC
D000818:Animals; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics; D015536:Down-Regulation; D015195:Drug Design; D004347:Drug Interactions; D017930:Genes, Reporter; D005938:Glucocorticoids / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D008954:Models, Biological; D009154:Mutation; D016328:NF-kappa B / Q000378:metabolism; D011965:Receptors, Glucocorticoid / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D016385:TATA Box; D018808:Transcription Factor AP-1 / Q000378:metabolism*
D005938:Glucocorticoids; D016328:NF-kappa B; D011965:Receptors, Glucocorticoid; D018808:Transcription Factor AP-1; D015500:Chloramphenicol O-Acetyltransferase